Andre Caron

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Enrichment of Fetal Cell-Free DNA in Early Miscarriages for Detection of Aneuploidy: A Novel Approach.

Enrichment of Fetal Cell-Free DNA in Early Miscarriages for Detection of Aneuploidy: A Novel Approach.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: January 29, 2026

SeraSeq reference materials support non-invasive cfDNA screening methods.

SeraSeq reference materials support non-invasive cfDNA screening methods.

Journal: Clinical biochemistry

Published: July 14, 2025

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age.

Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age.

Journal: Clinical genetics

Published: May 13, 2025

Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study.

Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study.

Journal: Genetics in medicine open

Published: April 03, 2025

Improving Fetal Fraction of Noninvasive Prenatal Screening Samples Collected in EDTA-Gel Tubes Using Gel Size Selection: A Head-To-Head Comparison of Methods.

Improving Fetal Fraction of Noninvasive Prenatal Screening Samples Collected in EDTA-Gel Tubes Using Gel Size Selection: A Head-To-Head Comparison of Methods.

Journal: The Journal of molecular diagnostics : JMD

Published: March 08, 2022

Effect of preexamination conditions in a centralized-testing model of non-invasive prenatal screening.

Effect of preexamination conditions in a centralized-testing model of non-invasive prenatal screening.

Journal: Clinical chemistry and laboratory medicine

Published: June 07, 2021

Validation of a New Protocol to Collect and Isolate Plasma from Pregnant Women for Noninvasive Prenatal Testing (NIPT).

Validation of a New Protocol to Collect and Isolate Plasma from Pregnant Women for Noninvasive Prenatal Testing (NIPT).

Journal: The journal of applied laboratory medicine

Published: May 14, 2020

Precision of Fetal DNA Fraction Estimation by Quantitative Polymerase Chain Reaction Quantification of a Differently Methylated Target in Noninvasive Prenatal Testing.

Precision of Fetal DNA Fraction Estimation by Quantitative Polymerase Chain Reaction Quantification of a Differently Methylated Target in Noninvasive Prenatal Testing.

Journal: Laboratory medicine

Published: November 23, 2019

Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study.

Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study.

Journal: European journal of human genetics : EJHG

Published: December 20, 2018

Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.

Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.

Journal: The journal of applied laboratory medicine

Published: September 07, 2018

Non-invasive prenatal aneuploidy testing: Critical diagnostic performance parameters predict sample z-score values.

Non-invasive prenatal aneuploidy testing: Critical diagnostic performance parameters predict sample z-score values.

Journal: Clinical biochemistry

Published: May 09, 2018

Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.

Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.

Journal: BJU international

Published: October 04, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026